9112 POSTER AVAPERL1 (MO22089) – Interim Safety of Maintenance (mtc) Bevacizumab (bev) + Pemetrexed (pern) in Patients (pts) With Advanced Non-squamous Non-small Cell Lung Cancer (nsNSCLC) After First-line (1L) Bev-cisplatin (cis)-pem Treatment (Tx)

✍ Scribed by Ahn, M.; Gervais, R.; Mezger, J.; Reck, M.; Orlov, S.; Burgers, J.A.; Bearz, A.; Grossi, F.; Lutiger, B.; Barlesi, F.

• Book ID: 122684957
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 42 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)72424-8